Biotech

All Articles

Metsera join Amneal to lock down GLP-1 supply

.Along with early period 1 data right now out in bush, metabolic disease outfit Metsera is losing no...

Rivus blog posts data to support muscle-sparing excessive weight medicine insurance claims

.Rivus Pharmaceuticals has actually revealed the information behind its stage 2 excessive weight win...

BMS pays out $110M to create T-cell treatment treaty, helping Prime get time to advance prioritized pipe

.Bristol Myers Squibb is paying out Top Medication $110 million beforehand to create reagents for ex...

Generate increases another $1B-plus Major Pharma collaboration

.Novartis has inked an offer likely worth more than $1 billion with Flagship-founded Generate: Biome...

Metsera GLP-1 records cut shows 7.5% weight reduction at 36 days

.Recently debuted Metsera is unfolding some period 1 information for its GLP-1 receptor agonist, sho...

Flagship hopes biotechs group to Mirai to improve hereditary medications

.Amidst the genetic medications branches ethnicity, Front runner Pioneering is unveiling a brand new...

BioAge eyes $180M from IPO, personal placement for obesity trials

.BioAge Labs is actually looking at around $180 million in first earnings from an IPO and also a pri...

Merck's LAG-3 combination stops working colorectal cancer stage 3 study

.An effort through Merck &amp Co. to uncover the microsatellite steady (MSS) metastatic colorectal c...

Spanish VC shuts $200M life scientific researches fund

.Spain-based Asabys Allies has actually closed a fund of 180 thousand euros ($ 200 million), money t...

BioAge generates $198M from IPO as obesity biotech participates in Nasdaq

.BioAge Labs is bringing in just about $200 million via its Nasdaq IPO today, with the earnings set ...